HIV infection is associated with gut microbiome alterations, enteropathy, and intestinal translocation of microbial products. It is unclear what HIV associated changes in the gut microbiome occur in HIV-infected individuals who control the disease immunologically without treatment, but they provide a unique model to investigate the effects of HIV infection.
Our Boston cohort (n=183), the largest of its kind, includes HIV-uninfected controls and three HIV-infected sub-groups: anti-retroviral treated (ART), chronic untreated with high viral loads, and immunologic controllers that maintain low viral loads without ART. Fecal microbial composition was determined by 16S amplicon sequencing. Serum inflammatory markers were measured by immunological assay. These data were analyzed with cohort metadata and clinical data, including dietary micronutrients and macronutrients. Candidate bacteria of significance were selected for an in vitro transepithelial resistance (TER) co-culture assay with Caco-2 cells to determine the epithelial cell response to potential commensals and pathogens associated with HIV infection.
HIV infection was the predominant correlative factor, with significant differences between the bacterial communities of uninfected and HIV-infected individuals regardless of ART or immunologic control. HIV infection was associated with loss of alpha diversity, relative decrease in the phyla Firmicutes and families Bifidobacteriaceae and Bacteroidaceae, and expansion of the family Prevotellaceae. This shift correlated with serum levels of sCD163, an inflammatory marker, in HIV-infected patients. However, controllers uniquely had serum levels of sCD14, a bacterially mediated inflammatory marker, similar to healthy controls despite elevations in other HIV-infected subgroups. Diet, micronutrient, and clinical cohort data were not significant correlative factors. Initial Caco-2 TER assay demonstrated that bacteria significantly enriched by HIV infection have a mixed effect on epithelial integrity.
Our findings demonstrate a complex model for how HIV may alter the gut microbiome and human host health. Our data suggests that bacterial communities, irrespective of means of HIV control, and inflammatory responses, with nuances, could be driven by HIV infection and baseline microbial community structure. However, this alone does not prove that the bacteria enriched in HIV infection elicit a pathogenic effect on the host and colonic epithelium as was previously presumed.